SciSparc secures Canadian patent for pain treatment
TEL AVIV - SciSparc Ltd. (NASDAQ:SPRC), a pharmaceutical company specializing in central nervous system disorders and rare diseases, has received a Canadian patent for a novel combination of opioids and n-acylethanolamines intended for pain management. The Canadian Intellectual Property Office granted the patent, signaling a potential advancement in the approach to treating chronic pain amid...